{ "run": { "id": "cmnr14kf8052cp658jv03n4t1", "region": "US", "assetId": "cmnr14keq0528p658prc9twzs", "ticker": "MET", "snapshotId": "cmnr14kev052ap6586hyaisyz", "promptTemplateId": "cmnqt07si0005lm3jzpxuu1ux", "createdAt": "2026-04-09T05:21:23.297Z", "promptTemplate": { "id": "cmnqt07si0005lm3jzpxuu1ux", "name": "Oficial 08.apr.2026", "version": 1 }, "snapshot": { "id": "cmnr14kev052ap6586hyaisyz", "assetId": "cmnr14keq0528p658prc9twzs", "asOf": "2026-04-08T20:00:02.000Z", "snapshot": { "asOf": "2026-04-08T20:00:02.000Z", "quote": { "asOf": "2026-04-08T20:00:02.000Z", "open": null, "price": 74.34, "dayLow": 73.125, "volume": 3487266, "dayHigh": 74.5, "currency": "USD", "prevClose": 71.2, "week52Low": 66.83, "week52High": 83.85 }, "fundamentals": { "pe": 16.6540084388186, "beta": 0.921942394072453, "epsTTM": 4.74, "fcfTTM": null, "growth": { "epsYoy": -0.2073578595317726, "revenueYoy": 0.08590426281238554 }, "sector": "Life Insurance", "margins": { "net": 0.04383529655959732, "gross": null, "operating": 0.07961444657775933 }, "website": "https://metlife.com/", "industry": "Financial services", "pegRatio": -0.803152987613992, "ebitdaTTM": 5784000000, "forwardPe": 7.9656912209889, "marketCap": 53600000000, "totalCash": 22032000000, "totalDebt": 14354000000, "debtEquity": 0.505458130854285, "quickRatio": null, "revenueTTM": 77084000000, "companyName": "METLIFE INC", "priceToBook": 1.82576556827219, "currentRatio": null, "dividendYield": 0.0285779401104097, "returnOnAssets": 0.0045345600845986, "returnOnEquity": 0.118987252623424, "analystOpinions": null, "businessSummary": "MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with around 90 million customers in over 60 countries. The firm was founded on March 24, 1868. MetLife ranked No. 43 in the 2018 Fortune 500 list of the largest United States corporations by total revenue.", "enterpriseValue": 45124966000, "analystTargetLow": null, "analystTargetHigh": null, "analystTargetMean": null, "fullTimeEmployees": 46000, "sharesOutstanding": 652053867, "enterpriseToEbitda": 7.801688450899031, "analystTargetMedian": null, "enterpriseToRevenue": 0.5853999014062581, "operatingCashflowTTM": 17092000000, "analystRecommendationKey": null } }, "createdAt": "2026-04-09T05:21:23.287Z" }, "results": [ { "id": "cmnr14kfb052ep658nm6te15k", "runId": "cmnr14kf8052cp658jv03n4t1", "modelId": "anthropic", "status": "SUCCESS", "rawOutput": "{\"model\":\"claude-3.7-sonnet-equity-v1\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"MET\",\"currency\":\"USD\",\"current_price\":74.34,\"target_price_6m\":78.5,\"target_price_12m\":83.0,\"recommendation\":\"BUY\",\"confidence\":0.62,\"thesis_bullets\":[\"Forward P/E of ~8x signals substantial earnings recovery ahead\",\"Attractive 2.9% dividend yield provides downside cushion\",\"ROE of 11.9% supports P/B near 1.8x as reasonable\",\"Price sits 11% below 52-week high suggesting re-rating room\",\"Strong operating cash flow of $17B supports buybacks and dividends\"],\"key_drivers\":[{\"driver\":\"Earnings normalization from depressed TTM EPS of $4.74 toward ~$9 forward\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Higher interest rate environment supports investment income\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Share buyback program reducing float and boosting EPS\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Global diversification across 60+ countries\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"EPS YoY decline of -20.7% signals recent earnings headwinds\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Macro uncertainty and potential recession risk on insurance demand\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Revenue growth of 8.6% YoY showing top-line momentum\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Life insurance sector facing secular shift toward fee-based models\",\"impact\":\"LOW\",\"direction\":\"NEG\"}],\"risks\":[\"Earnings recovery may disappoint if forward consensus is too optimistic\",\"Interest rate reversal would compress investment spreads\",\"Catastrophe or mortality tail events impacting reserves\",\"Regulatory changes in key global markets\",\"Credit deterioration in fixed income portfolio during downturn\"],\"assumptions\":{\"revenue_cagr_3y\":0.04,\"ebit_margin_target\":0.10,\"wacc\":0.10,\"terminal_multiple\":9.0},\"scenarios\":{\"bear\":{\"target_price\":62.0,\"prob\":0.2,\"notes\":\"Earnings recovery stalls, macro recession compresses multiple to ~7.5x forward EPS.\"},\"base\":{\"target_price\":83.0,\"prob\":0.55,\"notes\":\"Forward EPS normalizes ~$9.2, trades at ~9x with steady buybacks and dividends.\"},\"bull\":{\"target_price\":96.0,\"prob\":0.25,\"notes\":\"Strong earnings beat, ROE expansion to 14%+, re-rating toward 10x forward earnings.\"}},\"method_notes\":\"Insurer earnings-power valuation: forward P/E anchor using implied forward EPS (~$9.33 from snapshot forward P/E of 7.97). Applied normalized 9x multiple for base case. Cross-checked with P/B vs ROE framework (1.83x book at 11.9% ROE supports fair value). TTM-to-forward earnings gap is large, moderating confidence. 12M base target of $83 implies ~11.7% upside → BUY per rubric. Dividend yield adds ~2.9% to total return. Not investment advice.\"}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "claude-3.7-sonnet-equity-v1", "risks": [ "Earnings recovery may disappoint if forward consensus is too optimistic", "Interest rate reversal would compress investment spreads", "Catastrophe or mortality tail events impacting reserves", "Regulatory changes in key global markets", "Credit deterioration in fixed income portfolio during downturn" ], "ticker": "MET", "currency": "USD", "scenarios": { "base": { "prob": 0.55, "notes": "Forward EPS normalizes ~$9.2, trades at ~9x with steady buybacks and dividends.", "target_price": 83 }, "bear": { "prob": 0.2, "notes": "Earnings recovery stalls, macro recession compresses multiple to ~7.5x forward EPS.", "target_price": 62 }, "bull": { "prob": 0.25, "notes": "Strong earnings beat, ROE expansion to 14%+, re-rating toward 10x forward earnings.", "target_price": 96 } }, "confidence": 0.62, "assumptions": { "wacc": 0.1, "revenue_cagr_3y": 0.04, "terminal_multiple": 9, "ebit_margin_target": 0.1 }, "key_drivers": [ { "driver": "Earnings normalization from depressed TTM EPS of $4.74 toward ~$9 forward", "impact": "HIGH", "direction": "POS" }, { "driver": "Higher interest rate environment supports investment income", "impact": "HIGH", "direction": "POS" }, { "driver": "Share buyback program reducing float and boosting EPS", "impact": "MED", "direction": "POS" }, { "driver": "Global diversification across 60+ countries", "impact": "MED", "direction": "POS" }, { "driver": "EPS YoY decline of -20.7% signals recent earnings headwinds", "impact": "HIGH", "direction": "NEG" }, { "driver": "Macro uncertainty and potential recession risk on insurance demand", "impact": "MED", "direction": "NEG" }, { "driver": "Revenue growth of 8.6% YoY showing top-line momentum", "impact": "MED", "direction": "POS" }, { "driver": "Life insurance sector facing secular shift toward fee-based models", "impact": "LOW", "direction": "NEG" } ], "method_notes": "Insurer earnings-power valuation: forward P/E anchor using implied forward EPS (~$9.33 from snapshot forward P/E of 7.97). Applied normalized 9x multiple for base case. Cross-checked with P/B vs ROE framework (1.83x book at 11.9% ROE supports fair value). TTM-to-forward earnings gap is large, moderating confidence. 12M base target of $83 implies ~11.7% upside → BUY per rubric. Dividend yield adds ~2.9% to total return. Not investment advice.", "current_price": 74.34, "recommendation": "BUY", "thesis_bullets": [ "Forward P/E of ~8x signals substantial earnings recovery ahead", "Attractive 2.9% dividend yield provides downside cushion", "ROE of 11.9% supports P/B near 1.8x as reasonable", "Price sits 11% below 52-week high suggesting re-rating room", "Strong operating cash flow of $17B supports buybacks and dividends" ], "target_price_6m": 78.5, "target_price_12m": 83 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "anthropic", "webSearch": { "enabled": false, "maxToolCalls": 2, "disabledReason": null }, "pauseTurns": 0, "stopReason": "end_turn" }, "sanityIssues": [] }, "latencyMs": 38806, "createdAt": "2026-04-09T05:21:23.297Z", "usage": { "inputTokens": 3595, "outputTokens": 1655, "costUsd": 0.05935 } }, { "id": "cmnr14kfb052hp658e2fy1sq6", "runId": "cmnr14kf8052cp658jv03n4t1", "modelId": "deepseek.reasoner", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"AI Equity Research Model v1.0\",\n \"as_of\": \"2026-04-08T20:00:02.000Z\",\n \"ticker\": \"MET\",\n \"currency\": \"USD\",\n \"current_price\": 74.34,\n \"target_price_6m\": 78.0,\n \"target_price_12m\": 80.0,\n \"recommendation\": \"BUY\",\n \"confidence\": 0.65,\n \"thesis_bullets\": [\n \"Global scale with 90M customers provides stable revenue base.\",\n \"Revenue growth at 8.6% yoy offsets recent earnings decline.\",\n \"Forward P/E of 8.0 suggests undervaluation relative to peers.\",\n \"Dividend yield of 2.9% offers income during recovery phase.\",\n \"Cost initiatives and digital transformation to improve margins.\"\n ],\n \"key_drivers\": [\n {\"driver\": \"Interest Rate Trends\", \"impact\": \"HIGH\", \"direction\": \"POS\"},\n {\"driver\": \"Revenue Growth Rate\", \"impact\": \"MED\", \"direction\": \"POS\"},\n {\"driver\": \"Earnings Per Share Recovery\", \"impact\": \"HIGH\", \"direction\": \"POS\"},\n {\"driver\": \"Operating Margin Expansion\", \"impact\": \"MED\", \"direction\": \"POS\"},\n {\"driver\": \"Regulatory Compliance Costs\", \"impact\": \"MED\", \"direction\": \"NEG\"},\n {\"driver\": \"Investment Portfolio Yield\", \"impact\": \"HIGH\", \"direction\": \"POS\"},\n {\"driver\": \"Economic Growth Outlook\", \"impact\": \"HIGH\", \"direction\": \"POS\"},\n {\"driver\": \"Competitive Pricing Pressure\", \"impact\": \"LOW\", \"direction\": \"NEG\"}\n ],\n \"risks\": [\n \"Low interest rates persisting and reducing investment income.\",\n \"Unexpected increase in insurance claims or catastrophes.\",\n \"Adverse regulatory changes impacting product offerings.\",\n \"Global economic slowdown affecting premium growth.\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.06,\n \"ebit_margin_target\": 0.085,\n \"wacc\": 0.09,\n \"terminal_multiple\": 9.0\n },\n \"scenarios\": {\n \"bear\": {\"target_price\": 70.0, \"prob\": 0.2, \"notes\": \"Earnings decline continues with no rate relief.\"},\n \"base\": {\"target_price\": 80.0, \"prob\": 0.6, \"notes\": \"Moderate recovery in earnings and stable growth.\"},\n \"bull\": {\"target_price\": 90.0, \"prob\": 0.2, \"notes\": \"Strong economic rebound and interest rate hikes.\"}\n },\n \"method_notes\": \"Valuation based on forward P/E and assumed earnings growth. BUY due to 7.6% upside with medium confidence. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "AI Equity Research Model v1.0", "risks": [ "Low interest rates persisting and reducing investment income.", "Unexpected increase in insurance claims or catastrophes.", "Adverse regulatory changes impacting product offerings.", "Global economic slowdown affecting premium growth." ], "ticker": "MET", "currency": "USD", "scenarios": { "base": { "prob": 0.6, "notes": "Moderate recovery in earnings and stable growth.", "target_price": 80 }, "bear": { "prob": 0.2, "notes": "Earnings decline continues with no rate relief.", "target_price": 70 }, "bull": { "prob": 0.2, "notes": "Strong economic rebound and interest rate hikes.", "target_price": 90 } }, "confidence": 0.65, "assumptions": { "wacc": 0.09, "revenue_cagr_3y": 0.06, "terminal_multiple": 9, "ebit_margin_target": 0.085 }, "key_drivers": [ { "driver": "Interest Rate Trends", "impact": "HIGH", "direction": "POS" }, { "driver": "Revenue Growth Rate", "impact": "MED", "direction": "POS" }, { "driver": "Earnings Per Share Recovery", "impact": "HIGH", "direction": "POS" }, { "driver": "Operating Margin Expansion", "impact": "MED", "direction": "POS" }, { "driver": "Regulatory Compliance Costs", "impact": "MED", "direction": "NEG" }, { "driver": "Investment Portfolio Yield", "impact": "HIGH", "direction": "POS" }, { "driver": "Economic Growth Outlook", "impact": "HIGH", "direction": "POS" }, { "driver": "Competitive Pricing Pressure", "impact": "LOW", "direction": "NEG" } ], "method_notes": "Valuation based on forward P/E and assumed earnings growth. BUY due to 7.6% upside with medium confidence. Not investment advice.", "current_price": 74.34, "recommendation": "BUY", "thesis_bullets": [ "Global scale with 90M customers provides stable revenue base.", "Revenue growth at 8.6% yoy offsets recent earnings decline.", "Forward P/E of 8.0 suggests undervaluation relative to peers.", "Dividend yield of 2.9% offers income during recovery phase.", "Cost initiatives and digital transformation to improve margins." ], "target_price_6m": 78, "target_price_12m": 80 }, "errorsJson": { "attempts": [], "providerMeta": { "endpoint": "https://api.deepseek.com/v1/chat/completions", "provider": "deepseek", "webSearch": { "enabled": false, "supported": false }, "responseFormat": "json_object" }, "sanityIssues": [] }, "latencyMs": 374, "createdAt": "2026-04-09T05:21:23.297Z", "usage": { "inputTokens": 2108, "outputTokens": 4161, "costUsd": 0.002338 } }, { "id": "cmnr14kfb052fp658mhpn1n08", "runId": "cmnr14kf8052cp658jv03n4t1", "modelId": "gemini.3-pro", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"Equity Research AI - Financials\",\n \"as_of\": \"2026-04-08T20:00:02.000Z\",\n \"ticker\": \"MET\",\n \"currency\": \"USD\",\n \"current_price\": 74.34,\n \"target_price_6m\": 81.5,\n \"target_price_12m\": 88.0,\n \"recommendation\": \"BUY\",\n \"confidence\": 0.72,\n \"thesis_bullets\": [\n \"Strong market position in Group Benefits provides stable, high-margin cash flows.\",\n \"Diversified global footprint, particularly in high-growth Latin American and Asian markets.\",\n \"Significant capital return potential through consistent share repurchases and dividend growth.\",\n \"Higher interest rate environment supports improved new money yields on investment portfolios.\",\n \"Attractive valuation with forward P/E significantly below historical averages and peers.\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Interest rate spreads\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Group Benefits underwriting margins\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Commercial Real Estate (CRE) exposure\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Share repurchase volume\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Emerging market currency fluctuations\",\n \"impact\": \"LOW\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Mortality and morbidity trends\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n }\n ],\n \"risks\": [\n \"Credit cycle downturn affecting fixed income and CRE portfolios.\",\n \"Unfavorable regulatory changes in international jurisdictions.\",\n \"Volatility in equity markets impacting fee-based retirement products.\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.045,\n \"ebit_margin_target\": 0.12,\n \"wacc\": 0.095,\n \"terminal_multiple\": 10.5\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 65.0,\n \"prob\": 0.25,\n \"notes\": \"Significant credit losses in CRE and corporate debt portfolios.\"\n },\n \"base\": {\n \"target_price\": 88.0,\n \"prob\": 0.55,\n \"notes\": \"Steady earnings growth and continued aggressive share buyback program.\"\n },\n \"bull\": {\n \"target_price\": 102.0,\n \"prob\": 0.2,\n \"notes\": \"Rapid margin expansion and higher-than-expected investment income yields.\"\n }\n },\n \"method_notes\": \"Valuation derived from a 9.5x forward P/E multiple on normalized earnings power. Recommendation reflects ~18% upside potential driven by capital management and rate tailwinds. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "Equity Research AI - Financials", "risks": [ "Credit cycle downturn affecting fixed income and CRE portfolios.", "Unfavorable regulatory changes in international jurisdictions.", "Volatility in equity markets impacting fee-based retirement products." ], "ticker": "MET", "currency": "USD", "scenarios": { "base": { "prob": 0.55, "notes": "Steady earnings growth and continued aggressive share buyback program.", "target_price": 88 }, "bear": { "prob": 0.25, "notes": "Significant credit losses in CRE and corporate debt portfolios.", "target_price": 65 }, "bull": { "prob": 0.2, "notes": "Rapid margin expansion and higher-than-expected investment income yields.", "target_price": 102 } }, "confidence": 0.72, "assumptions": { "wacc": 0.095, "revenue_cagr_3y": 0.045, "terminal_multiple": 10.5, "ebit_margin_target": 0.12 }, "key_drivers": [ { "driver": "Interest rate spreads", "impact": "HIGH", "direction": "POS" }, { "driver": "Group Benefits underwriting margins", "impact": "HIGH", "direction": "POS" }, { "driver": "Commercial Real Estate (CRE) exposure", "impact": "MED", "direction": "NEG" }, { "driver": "Share repurchase volume", "impact": "MED", "direction": "POS" }, { "driver": "Emerging market currency fluctuations", "impact": "LOW", "direction": "NEG" }, { "driver": "Mortality and morbidity trends", "impact": "HIGH", "direction": "NEG" } ], "method_notes": "Valuation derived from a 9.5x forward P/E multiple on normalized earnings power. Recommendation reflects ~18% upside potential driven by capital management and rate tailwinds. Not investment advice.", "current_price": 74.34, "recommendation": "BUY", "thesis_bullets": [ "Strong market position in Group Benefits provides stable, high-margin cash flows.", "Diversified global footprint, particularly in high-growth Latin American and Asian markets.", "Significant capital return potential through consistent share repurchases and dividend growth.", "Higher interest rate environment supports improved new money yields on investment portfolios.", "Attractive valuation with forward P/E significantly below historical averages and peers." ], "target_price_6m": 81.5, "target_price_12m": 88 }, "errorsJson": { "attempts": [], "providerMeta": { "model": "gemini-3-flash-preview", "provider": "gemini", "webSearch": { "used": false, "allowed": false, "enabled": false, "requested": false, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 16659, "createdAt": "2026-04-09T05:21:23.297Z", "usage": { "inputTokens": 2438, "outputTokens": 770, "costUsd": 0.014116 } }, { "id": "cmnr14kfb052dp658zyz71fz6", "runId": "cmnr14kf8052cp658jv03n4t1", "modelId": "openai.gpt-5.4", "status": "SUCCESS", "rawOutput": "{\"model\":\"gpt-5\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"MET\",\"currency\":\"USD\",\"current_price\":74.34,\"target_price_6m\":77.5,\"target_price_12m\":79.5,\"recommendation\":\"BUY\",\"confidence\":0.62,\"thesis_bullets\":[\"Forward P/E below 8x implies modest expectations for a high-quality franchise.\",\"Strong cash, buybacks, and dividends support shareholder returns and downside resilience.\",\"ROE near 12% is healthy, but 1.8x book limits multiple expansion.\",\"Recent EPS contraction and investment income volatility argue for only moderate upside.\",\"Base case assumes steady spread income, claims, and continued expense discipline.\"],\"key_drivers\":[{\"driver\":\"capital returns\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"reinvestment spreads\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"group benefits volume\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"retirement platform flows\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"variable investment income\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"mortality and morbidity claims\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"credit portfolio losses\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"expense control\",\"impact\":\"LOW\",\"direction\":\"POS\"}],\"risks\":[\"Falling rates compress portfolio yields and spreads\",\"Credit losses or downgrades hit investment income and capital\",\"Weaker capital markets reduce fee income and annuity demand\",\"Unexpected mortality, morbidity, or catastrophe claims\",\"Regulatory changes limit capital return flexibility\"],\"assumptions\":{\"revenue_cagr_3y\":0.04,\"ebit_margin_target\":0.085,\"wacc\":0.095,\"terminal_multiple\":8.5},\"scenarios\":{\"bear\":{\"target_price\":65,\"prob\":0.25,\"notes\":\"Rates fall and claims or credit costs disappoint.\"},\"base\":{\"target_price\":79.5,\"prob\":0.5,\"notes\":\"Core growth and buybacks offset mixed macro and market income.\"},\"bull\":{\"target_price\":92,\"prob\":0.25,\"notes\":\"Higher spreads and cleaner results drive a modest rerating.\"}},\"method_notes\":\"12M target uses snapshot forward P/E-implied earnings power valued at the assumed 8.5x multiple, cross-checked with P/B, ROE and dividend yield. Snapshot quote fields were kept authoritative; no sell-side price targets used. not investment advice\"}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "gpt-5", "risks": [ "Falling rates compress portfolio yields and spreads", "Credit losses or downgrades hit investment income and capital", "Weaker capital markets reduce fee income and annuity demand", "Unexpected mortality, morbidity, or catastrophe claims", "Regulatory changes limit capital return flexibility" ], "ticker": "MET", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Core growth and buybacks offset mixed macro and market income.", "target_price": 79.5 }, "bear": { "prob": 0.25, "notes": "Rates fall and claims or credit costs disappoint.", "target_price": 65 }, "bull": { "prob": 0.25, "notes": "Higher spreads and cleaner results drive a modest rerating.", "target_price": 92 } }, "confidence": 0.62, "assumptions": { "wacc": 0.095, "revenue_cagr_3y": 0.04, "terminal_multiple": 8.5, "ebit_margin_target": 0.085 }, "key_drivers": [ { "driver": "capital returns", "impact": "HIGH", "direction": "POS" }, { "driver": "reinvestment spreads", "impact": "HIGH", "direction": "POS" }, { "driver": "group benefits volume", "impact": "MED", "direction": "POS" }, { "driver": "retirement platform flows", "impact": "MED", "direction": "POS" }, { "driver": "variable investment income", "impact": "MED", "direction": "NEG" }, { "driver": "mortality and morbidity claims", "impact": "MED", "direction": "NEG" }, { "driver": "credit portfolio losses", "impact": "HIGH", "direction": "NEG" }, { "driver": "expense control", "impact": "LOW", "direction": "POS" } ], "method_notes": "12M target uses snapshot forward P/E-implied earnings power valued at the assumed 8.5x multiple, cross-checked with P/B, ROE and dividend yield. Snapshot quote fields were kept authoritative; no sell-side price targets used. not investment advice", "current_price": 74.34, "recommendation": "BUY", "thesis_bullets": [ "Forward P/E below 8x implies modest expectations for a high-quality franchise.", "Strong cash, buybacks, and dividends support shareholder returns and downside resilience.", "ROE near 12% is healthy, but 1.8x book limits multiple expansion.", "Recent EPS contraction and investment income volatility argue for only moderate upside.", "Base case assumes steady spread income, claims, and continued expense discipline." ], "target_price_6m": 77.5, "target_price_12m": 79.5 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "openai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "resp_06978612b0065c750069d75b42735081908ffba70e6c9c8652", "reasoningEffort": "medium", "structuredOutputs": { "used": true, "requested": true, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 56456, "createdAt": "2026-04-09T05:21:23.297Z", "usage": { "inputTokens": 2379, "outputTokens": 2653, "costUsd": 0.041305 } }, { "id": "cmnr14kfb052gp658hta3hkpm", "runId": "cmnr14kf8052cp658jv03n4t1", "modelId": "xai.grok-4.20-reasoning", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"Blended P/E-P/B Model\",\n \"as_of\": \"2026-04-08T20:00:02.000Z\",\n \"ticker\": \"MET\",\n \"currency\": \"USD\",\n \"current_price\": 74.34,\n \"target_price_6m\": 79.0,\n \"target_price_12m\": 85.0,\n \"recommendation\": \"BUY\",\n \"confidence\": 0.61,\n \"thesis_bullets\": [\n \"Forward P/E near 8x signals undervaluation.\",\n \"Stable revenue growth and strong cash flow.\",\n \"Higher rates provide tailwind to investment income.\",\n \"Negative EPS trend reflects one-time pressures.\",\n \"Solid capital supports dividends and buybacks.\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Interest rate levels\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Premium revenue growth\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Investment portfolio returns\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Mortality/claims experience\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Equity market performance\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Regulatory environment\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Operating cost efficiency\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Economic slowdown\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n }\n ],\n \"risks\": [\n \"Higher than expected claims\",\n \"Falling interest rates\",\n \"Investment portfolio losses\",\n \"Regulatory tightening\",\n \"Intense industry competition\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.05,\n \"ebit_margin_target\": 0.09,\n \"wacc\": 0.085,\n \"terminal_multiple\": 10\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 67,\n \"prob\": 0.3,\n \"notes\": \"Elevated claims and rate declines reduce earnings.\"\n },\n \"base\": {\n \"target_price\": 85,\n \"prob\": 0.5,\n \"notes\": \"Steady growth and stable margins yield moderate upside.\"\n },\n \"bull\": {\n \"target_price\": 99,\n \"prob\": 0.2,\n \"notes\": \"Favorable rates and markets accelerate earnings growth.\"\n }\n },\n \"method_notes\": \"Forward P/E (9x target) and P/B (1.9x) blend using 5% CAGR, 8.5% WACC, 10x terminal. 14% 12M upside fits BUY rubric. Snapshot data used exclusively for price/quote. not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "Blended P/E-P/B Model", "risks": [ "Higher than expected claims", "Falling interest rates", "Investment portfolio losses", "Regulatory tightening", "Intense industry competition" ], "ticker": "MET", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Steady growth and stable margins yield moderate upside.", "target_price": 85 }, "bear": { "prob": 0.3, "notes": "Elevated claims and rate declines reduce earnings.", "target_price": 67 }, "bull": { "prob": 0.2, "notes": "Favorable rates and markets accelerate earnings growth.", "target_price": 99 } }, "confidence": 0.61, "assumptions": { "wacc": 0.085, "revenue_cagr_3y": 0.05, "terminal_multiple": 10, "ebit_margin_target": 0.09 }, "key_drivers": [ { "driver": "Interest rate levels", "impact": "HIGH", "direction": "POS" }, { "driver": "Premium revenue growth", "impact": "HIGH", "direction": "POS" }, { "driver": "Investment portfolio returns", "impact": "HIGH", "direction": "POS" }, { "driver": "Mortality/claims experience", "impact": "HIGH", "direction": "NEG" }, { "driver": "Equity market performance", "impact": "MED", "direction": "POS" }, { "driver": "Regulatory environment", "impact": "MED", "direction": "NEG" }, { "driver": "Operating cost efficiency", "impact": "MED", "direction": "POS" }, { "driver": "Economic slowdown", "impact": "MED", "direction": "NEG" } ], "method_notes": "Forward P/E (9x target) and P/B (1.9x) blend using 5% CAGR, 8.5% WACC, 10x terminal. 14% 12M upside fits BUY rubric. Snapshot data used exclusively for price/quote. not investment advice.", "current_price": 74.34, "recommendation": "BUY", "thesis_bullets": [ "Forward P/E near 8x signals undervaluation.", "Stable revenue growth and strong cash flow.", "Higher rates provide tailwind to investment income.", "Negative EPS trend reflects one-time pressures.", "Solid capital supports dividends and buybacks." ], "target_price_6m": 79, "target_price_12m": 85 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "xai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "d19a61ed-7610-9644-8af2-f26790a94387", "usedFallbackChatCompletions": false }, "sanityIssues": [] }, "latencyMs": 13870, "createdAt": "2026-04-09T05:21:23.297Z", "usage": { "inputTokens": 2719, "outputTokens": 3060, "costUsd": 0.054057 } } ] } }